argumentA line of reasoning from premises to a conclusion. Like a claim, it belongs to no one who makes it.constitution →

LDL-lowering mechanism

forThis argument, if it holds, bears in favour of the claim.constitution →Adding ezetimibe to statin therapy reduces cardiovascular events

The argument

Because linked claim, and given that linked claim, adding ezetimibe to a statin should produce a proportional reduction in cardiovascular events. The direct outcomes evidence from the IMPROVE-IT trial tests and confirms this predicted benefit.

Does it work?

Not yet evaluated.

Premises

UnassessedNo current assessment. Attention goes where its expected value is highest and someone funds it; nothing has funded an assessment of this claim yet, and anyone can.constitution →Ezetimibe added to statin therapy further lowers LDL cholesterol
VerifiedThe evidence, examined directly, establishes the claim.constitution →Randomized trials show lowering LDL cholesterol reduces cardiovascular events proportionally to the reduction achieved

Where it is made

Passages where sources make, criticize or mention this argument. They record where it appears, not how strong it is, and none has precedence over another.

No source is recorded as making it.

Earlier ratings

Jul 19, 2026
The inference goes through: ezetimibe further lowers LDL is uncontested, and LDL lowering reduces events proportionally to the reduction achieved is verified, so a proportional event reduction is predicted. The one caveat is that the proportionality holds specifically for LDL lowered via the LDL-receptor pathway; ezetimibe acts through that pathway, and its dedicated outcomes trial confirms the predicted benefit directly, so the argument does not rest on the mechanistic step alone.